Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Cuevas Sales (Hospitalet de Llobregat, Barcelona, Spain), D. Huertas Almela (Satn Pere de Ribes, Barcelona, Spain), Y. Pascual González (Hospitalet de Llobregat, Barcelona, Spain), M. López Sánchez (Hospitalet de Llobregat, Barcelona, Spain), C. Montón Soler (Sabadell, Barcelona, Spain), X. Pomares Amigó (Sabadell, Barcelona, Spain), A. Marin Tàpia (Badalona, Barcelona, Spain), M. García Núñez (Sabadell, Barcelona, Spain), S. Martí Martí (Hospitalet de Llobregat, Barcelona, Spain), S. Santos Pérez (Hospitalet de Llobregat, Barcelona, Spain). SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS. 261

Member's Comments

No comment yet.

Related content which might interest you: PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA Source: International Congress 2018 – New modalities in asthma treatment Year: 2018 “A RANDOMISED CONTROLLED STUDY ON EFFECT OF ORAL MAGNESIUM SUPPLEMENTS IN CONTROL OF SYMPTOMS OF BRONCHIAL ASTHMA AND LUNG FUNCTION PARAMETERS” Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 A COMPARATIVE STUDY ON EFFECTS OF SUBSTANCE DEPENDENCE ON PULMONARY TUBERCULOSIS PATIENTS Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 PHYSIOLOGICAL EFFECTS OF THREE DIFFERENT VENTILATORY MODES IN PATIENTS WITH OBESITY HYPOVENTILATION SYNDROME UNDER NOCTURNAL NONINVASIVE VENTILATION: A PILOT RANDOMIZED STUDY Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure Year: 2017 FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 UTILITY OF THE HIGH FLOW WITH NASAL CANNULA IN THE DECANULATION OF TRAQUEOTOMIZED PATIENTS DURING AN EPISODE OF ACUTE RESPIRATORY INSUFFICIENCY. Source: International Congress 2018 – New tools for managing respiratory failure Year: 2018 BLOOD PRESSURE EFFECTS OF OBSTRUCTIVE SLEEP APNEA TREATMENT BY CONTINUOUS POSITIVE AIRWAY PRESSURE: SYSTEMATIC REVIEW, METAANALYSIS AND EVALUATION OF PHENOTYPES PREDICTING RESPONSE Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 QUALITY OF LIFE IN SMOKERS FOLLOWING SMOKING CESSATION TREATMENT Source: International Congress 2017 – Smoking cessation Year: 2017 THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD. Source: Eur Respir J 2006; 27: 1076 Year: 2006 THE IMPACT OF REFLEXOLOGY AND HOMEOPATHY ADDED TO CONVENTIONAL ASTHMA TREATMENT ON MARKERS OF AIRWAY INFLAMMATION– A RANDOMISED STUDY Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020